BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of tetrahydroisoquinoline-derived antibacterial compounds. 2022

Matthew Payne, and Amy L Bottomley, and Anthony Och, and Hugh G Hiscocks, and Anjar P Asmara, and Elizabeth J Harry, and Alison T Ung
School of Mathematical and Physical Sciences, Faculty of Science, University of Technology Sydney, Broadway, NSW, 2007, Australia.

Antibiotic resistance is one of the greatest threats to modern medicine. Drugs that were once routinely used to treat infections are being rendered ineffective, increasing the demand for novel antibiotics with low potential for resistance. Here we report the synthesis of 18 novel cationic tetrahydroisoquinoline-triazole compounds. Five of the developed molecules were active against S. aureus at a low MIC of 2-4 μg/mL. Hit compound 4b was also found to eliminate M. tuberculosis H37Rv at MIC of 6 μg/mL. This potent molecule was found to eliminate S. aureus effectively, with no resistance observed after thirty days of sequential passaging. These results identified compound 4b and its analogues as potential candidates for further drug development that could help tackle the threat of antibiotic resistance.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D044005 Tetrahydroisoquinolines A group of ISOQUINOLINES in which the nitrogen containing ring is protonated. They derive from the non-enzymatic Pictet-Spengler condensation of CATECHOLAMINES with ALDEHYDES. Tetrahydro-Isoquinoline,1,2,3,4-Tetrahydroisoquinolines,Tetrahydro-Isoquinolines,Tetrahydro Isoquinoline,Tetrahydro Isoquinolines

Related Publications

Matthew Payne, and Amy L Bottomley, and Anthony Och, and Hugh G Hiscocks, and Anjar P Asmara, and Elizabeth J Harry, and Alison T Ung
[The synthesis and biological activity of substituted tetrahydroisoquinoline compounds].
January 1990, Yao xue xue bao = Acta pharmaceutica Sinica,
Matthew Payne, and Amy L Bottomley, and Anthony Och, and Hugh G Hiscocks, and Anjar P Asmara, and Elizabeth J Harry, and Alison T Ung
Design, synthesis, and biological antitumor evaluation of tetrahydroisoquinoline derivatives.
May 2024, Bioorganic & medicinal chemistry letters,
Matthew Payne, and Amy L Bottomley, and Anthony Och, and Hugh G Hiscocks, and Anjar P Asmara, and Elizabeth J Harry, and Alison T Ung
Design, synthesis, and biological evaluation of simplified tetrahydroisoquinoline analogs.
December 2023, Archiv der Pharmazie,
Matthew Payne, and Amy L Bottomley, and Anthony Och, and Hugh G Hiscocks, and Anjar P Asmara, and Elizabeth J Harry, and Alison T Ung
Synthesis and biological evaluation of new antiseizure compounds derived from valproic acid.
May 2023, Future medicinal chemistry,
Matthew Payne, and Amy L Bottomley, and Anthony Och, and Hugh G Hiscocks, and Anjar P Asmara, and Elizabeth J Harry, and Alison T Ung
Antibacterial activity of xylose-derived LpxC inhibitors - Synthesis, biological evaluation and molecular docking studies.
February 2021, Bioorganic chemistry,
Matthew Payne, and Amy L Bottomley, and Anthony Och, and Hugh G Hiscocks, and Anjar P Asmara, and Elizabeth J Harry, and Alison T Ung
Synthesis and Biological Evaluation of 3-Amidoquinuclidine Quaternary Ammonium Compounds as New Soft Antibacterial Agents.
January 2023, Pharmaceuticals (Basel, Switzerland),
Matthew Payne, and Amy L Bottomley, and Anthony Och, and Hugh G Hiscocks, and Anjar P Asmara, and Elizabeth J Harry, and Alison T Ung
Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives as potential antitumor candidate.
March 2017, Chemical biology & drug design,
Matthew Payne, and Amy L Bottomley, and Anthony Och, and Hugh G Hiscocks, and Anjar P Asmara, and Elizabeth J Harry, and Alison T Ung
Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
October 2015, Bioorganic & medicinal chemistry letters,
Matthew Payne, and Amy L Bottomley, and Anthony Och, and Hugh G Hiscocks, and Anjar P Asmara, and Elizabeth J Harry, and Alison T Ung
Design, synthesis, and biological evaluation of tetrahydroisoquinoline stilbene derivatives as potential antitumor candidates.
February 2023, Chemical biology & drug design,
Matthew Payne, and Amy L Bottomley, and Anthony Och, and Hugh G Hiscocks, and Anjar P Asmara, and Elizabeth J Harry, and Alison T Ung
Design, Synthesis, and Biological Evaluation of Tetrahydroisoquinoline-Based Histone Deacetylase 8 Selective Inhibitors.
August 2017, ACS medicinal chemistry letters,
Copied contents to your clipboard!